Stay updated on Elamipretide in AMD Non-central GA Clinical Trial
Sign up to get notified when there's something new on the Elamipretide in AMD Non-central GA Clinical Trial page.

Latest updates to the Elamipretide in AMD Non-central GA Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision history updated: added Revision v3.5.0 and removed Revision v3.4.3.SummaryDifference0.0%

- Check25 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check39 days agoChange DetectedNo visible changes between the two screenshots; the page content and layout appear the same as before.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision: v3.4.2 was applied to the site, and the prior government funding lapse notice (v3.4.1) was removed. This appears to be an administrative update that does not affect study content, eligibility, or results.SummaryDifference0.3%

- Check60 days agoChange DetectedA site-wide notice regarding government funding lapse and NIH Clinical Center status was added. The page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check67 days agoChange DetectedUI and metadata updates include showing the glossary, capitalization adjustments to QC criteria labels (Last Update Submitted that Met QC Criteria), and the addition of 'No FEAR Act Data' with a revision tag updated to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Elamipretide in AMD Non-central GA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elamipretide in AMD Non-central GA Clinical Trial page.